PMC:7559350 / 22392-22731 JSONTXT

{"project":"LitCovid_Glycan-Motif-Structure","denotations":[{"id":"T22","span":{"begin":217,"end":219},"obj":"https://glytoucan.org/Structures/Glycans/G93424OB"},{"id":"T23","span":{"begin":233,"end":235},"obj":"https://glytoucan.org/Structures/Glycans/G93424OB"}],"text":"Alanio et al. Single center prospective France (9/27; 33.3%) [12] 53/M Hypertension, obesity, ischemic heart disease Dexamethasone IV 20 mg once daily from day 1 to 5 followed by 10 mg once daily from day 6 to 10 GM Serum = 0.13/GM BALF = 0.89/BDG = 523/qPCR BALF and serum = negative Negative culture N/C N/A N/A N/A None Alive"}

{"project":"LitCovid-PubTator","denotations":[{"id":"967","span":{"begin":73,"end":85},"obj":"Disease"},{"id":"968","span":{"begin":87,"end":94},"obj":"Disease"},{"id":"969","span":{"begin":96,"end":118},"obj":"Disease"}],"attributes":[{"id":"A967","pred":"tao:has_database_id","subj":"967","obj":"MESH:D006973"},{"id":"A968","pred":"tao:has_database_id","subj":"968","obj":"MESH:D009765"},{"id":"A969","pred":"tao:has_database_id","subj":"969","obj":"MESH:D003324"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Alanio et al. Single center prospective France (9/27; 33.3%) [12] 53/M Hypertension, obesity, ischemic heart disease Dexamethasone IV 20 mg once daily from day 1 to 5 followed by 10 mg once daily from day 6 to 10 GM Serum = 0.13/GM BALF = 0.89/BDG = 523/qPCR BALF and serum = negative Negative culture N/C N/A N/A N/A None Alive"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T46","span":{"begin":73,"end":85},"obj":"Phenotype"},{"id":"T47","span":{"begin":87,"end":94},"obj":"Phenotype"}],"attributes":[{"id":"A46","pred":"hp_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0001513"}],"text":"Alanio et al. Single center prospective France (9/27; 33.3%) [12] 53/M Hypertension, obesity, ischemic heart disease Dexamethasone IV 20 mg once daily from day 1 to 5 followed by 10 mg once daily from day 6 to 10 GM Serum = 0.13/GM BALF = 0.89/BDG = 523/qPCR BALF and serum = negative Negative culture N/C N/A N/A N/A None Alive"}

{"project":"LitCovid-sentences","denotations":[{"id":"T138","span":{"begin":0,"end":13},"obj":"Sentence"},{"id":"T139","span":{"begin":14,"end":339},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Alanio et al. Single center prospective France (9/27; 33.3%) [12] 53/M Hypertension, obesity, ischemic heart disease Dexamethasone IV 20 mg once daily from day 1 to 5 followed by 10 mg once daily from day 6 to 10 GM Serum = 0.13/GM BALF = 0.89/BDG = 523/qPCR BALF and serum = negative Negative culture N/C N/A N/A N/A None Alive"}